Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · IEX Real-Time Price · USD
10.53
-0.25 (-2.32%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $1.04 billion as of April 18, 2024. Its market cap has increased by 188.20% in one year.
Market Cap
1.04B
Enterprise Value
875.05M
1-Year Change
188.20%
Ranking
Category
Stock Price
$10.53
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has decreased from $1.75B to $1.04B, a decrease of -40.51%. That is a compound annual growth rate of -16.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 1.11B | 2.32% |
Apr 15, 2024 | 1.08B | -4.77% |
Apr 12, 2024 | 1.14B | -4.63% |
Apr 11, 2024 | 1.19B | 6.46% |
Apr 10, 2024 | 1.12B | -1.38% |
Apr 9, 2024 | 1.13B | 5.17% |
Apr 8, 2024 | 1.08B | - |
Apr 5, 2024 | 1.08B | 3.66% |
Apr 4, 2024 | 1.04B | -4.16% |
Apr 3, 2024 | 1.09B | -4.51% |
Apr 2, 2024 | 1.14B | 2.26% |
Apr 1, 2024 | 1.11B | -1.95% |
Mar 28, 2024 | 1.13B | 4.60% |
Mar 27, 2024 | 1.08B | 3.16% |
Mar 26, 2024 | 1.05B | -6.51% |
Mar 25, 2024 | 1.12B | -5.66% |
Mar 22, 2024 | 1.19B | 0.99% |
Mar 21, 2024 | 1.18B | 2.03% |
Mar 20, 2024 | 1.16B | 6.00% |
Mar 19, 2024 | 1.09B | 5.18% |
Mar 18, 2024 | 1.04B | -1.21% |
Mar 15, 2024 | 1.05B | 2.67% |
Mar 14, 2024 | 1.02B | -3.50% |
Mar 13, 2024 | 1.06B | -0.09% |
Mar 12, 2024 | 1.06B | 11.39% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Collegium Pharmaceutical | 1.12B |
Prothena Corporation | 1.11B |
Vir Biotechnology | 1.09B |
Scholar Rock Holding | 1.08B |
Liquidia | 1.07B |
Immatics | 1.05B |
Maravai LifeSciences Holdings | 1.02B |
Bicycle Therapeutics | 1.02B |